RemeGen Co., Ltd.
RemeGen Co., Ltd. Fundamental Analysis
RemeGen Co., Ltd. (REGMF) shows strong financial fundamentals with a PE ratio of 59.33, profit margin of 21.41%, and ROE of 27.45%. The company generates $3.3B in annual revenue with strong year-over-year growth of 89.36%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 75.6/100 based on profitability, valuation, growth, and balance sheet metrics. The B grade reflects solid fundamentals with room for improvement in valuation or growth.
Fundamental Health Score
We analyze REGMF's fundamental strength across five key dimensions:
Efficiency Score
WeakREGMF struggles to generate sufficient returns from assets.
Valuation Score
ModerateREGMF shows balanced valuation metrics.
Growth Score
ModerateREGMF shows steady but slowing expansion.
Financial Health Score
ExcellentREGMF maintains a strong and stable balance sheet.
Profitability Score
ModerateREGMF maintains healthy but balanced margins.
Key Financial Metrics
Is REGMF Expensive or Cheap?
P/E Ratio
REGMF trades at 59.33 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, REGMF's PEG of 0.05 indicates potential undervaluation.
Price to Book
The market values RemeGen Co., Ltd. at 11.34 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 125.10 times EBITDA. This signals the market has high growth expectations.
How Well Does REGMF Make Money?
Net Profit Margin
For every $100 in sales, RemeGen Co., Ltd. keeps $21.41 as profit after all expenses.
Operating Margin
Core operations generate 2.37 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $27.45 in profit for every $100 of shareholder equity.
ROA
RemeGen Co., Ltd. generates $9.52 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
RemeGen Co., Ltd. generates limited operating cash flow of $57.02M, signaling weaker underlying cash strength.
Free Cash Flow
RemeGen Co., Ltd. generates weak or negative free cash flow of $-150.69M, restricting financial flexibility.
FCF Per Share
Each share generates $-0.27 in free cash annually.
FCF Yield
REGMF converts -0.35% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
59.33
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.05
vs 25 benchmark
P/B Ratio
Price to book value ratio
11.34
vs 25 benchmark
P/S Ratio
Price to sales ratio
13.08
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.61
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.43
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.27
vs 25 benchmark
ROA
Return on assets percentage
0.10
vs 25 benchmark
ROCE
Return on capital employed
0.02
vs 25 benchmark
How REGMF Stacks Against Its Sector Peers
| Metric | REGMF Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 59.33 | 28.23 | Worse (Expensive) |
| ROE | 27.45% | 737.00% | Weak |
| Net Margin | 21.41% | -46175.00% (disorted) | Strong |
| Debt/Equity | 0.61 | 0.35 | Weak (High Leverage) |
| Current Ratio | 1.43 | 4.10 | Neutral |
| ROA | 9.52% | -17785.00% (disorted) | Weak |
REGMF outperforms its industry in 1 out of 6 key metrics, particularly excelling in Net Margin, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews RemeGen Co., Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
0.00%
Industry Style: Defensive, Growth, Innovation
DecliningEPS CAGR
175.45%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
100.00%
Industry Style: Defensive, Growth, Innovation
High Growth